Triple malaria therapies: the answer to resistance?
Against a backdrop of rising rates of antimicrobial resistance the world over, a new means of treatment able for immediate use has shown success. The first clinical trial of two triple artemisinin-based combination therapies (TACTs) for malaria has found the combinations to be both highly effective and well-tolerated. The study, published in The Lancet, …
Triple malaria therapies: the answer to resistance? Read More »
